Polymeric nanoparticles: Promising platform for drug delivery.

Nano medicine had viewed countless breakthroughs in drug delivery implementations. The main objective of nanotechnology application in delivering and carrying many promising therapeutics is to assure drugs carriage to their action sites, to maximize the pharmacological desired influence of remedies and to overcome their limitations and drawbacks that would hinder the required effectiveness. One of these applications was the particulates type of nano-range in size and tremendous impact in achievement. About this specific diversity of particulates, the different elaboration methodologies, mandatory and elementary components for design, and examples of splendid success stories for these particulates were emphasized in this humble review. Challenges such as oral delivery probability for peptide moieties and enhancement the harshly passage process of drugs across the blood brain barriers were accepted and defeated by the almost insurmountable latterly mentioned particulates. Behold, the polymeric nanoparticles.

[1]  Mafalda Videira,et al.  In vivo delivery of peptides and Toll-like receptor ligands by mannose-functionalized polymeric nanoparticles induces prophylactic and therapeutic anti-tumor immune responses in a melanoma model. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[2]  Patrick Couvreur,et al.  A Nanomedicine Transports a Peptide Caspase-3 Inhibitor across the Blood–Brain Barrier and Provides Neuroprotection , 2009, The Journal of Neuroscience.

[3]  Sergey A Piletsky,et al.  Polymeric nanoparticles for optical sensing. , 2013, Biotechnology advances.

[4]  Tianwei Tan,et al.  Studies on the oridonin-loaded poly(D,L-lactic acid) nanoparticles in vitro and in vivo. , 2007, International journal of biological macromolecules.

[5]  Vijay Kumar,et al.  Sterically stabilized polymeric nanoparticles with a combinatorial approach for multi drug resistant cancer: in vitro and in vivo investigations. , 2014, International journal of pharmaceutics.

[6]  Mark B. Carter,et al.  Erratum: The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers (Nature Materials (2011) 10 (389-397)) , 2011 .

[7]  Rogério Gaspar,et al.  Macrophage Activation by Polymeric Nanoparticles of Polyalkylcyanoacrylates: Activity Against Intracellular Leishmania donovani Associated with Hydrogen Peroxide Production , 1992, Pharmaceutical Research.

[8]  Qingfei Liu,et al.  Pharmacokinetics and biodistribution of surface modification polymeric nanoparticles , 2008, Archives of pharmacal research.

[9]  W. D. de Jong,et al.  Drug delivery and nanoparticles: Applications and hazards , 2008, International journal of nanomedicine.

[10]  Noritada Kaji,et al.  Nanospheres for DNA separation chips , 2004, Nature Biotechnology.

[11]  Tariq Yasin,et al.  Encapsulation of Ellipticine in poly-(3-hydroxybutyrate-co-3-hydroxyvalerate) based nanoparticles and its in vitro application. , 2013, Materials science & engineering. C, Materials for biological applications.

[12]  Lei Han,et al.  Inhibition of C6 glioma in vivo by combination chemotherapy of implantation of polymer wafer and intracarotid perfusion of transferrin-decorated nanoparticles. , 2011, Oncology reports.

[13]  Kohei Tahara,et al.  Chitosan-modified poly(d,l-lactide-co-glycolide) nanospheres for improving siRNA delivery and gene-silencing effects , 2009, European Journal of Pharmaceutics and Biopharmaceutics.

[14]  L. Brannon-Peppas,et al.  Nanoparticle and targeted systems for cancer therapy. , 2004, Advanced drug delivery reviews.

[15]  J. Clegg,et al.  Poly(DL-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration. , 1997, Vaccine.

[16]  ブジェチェコ，アルバート・ダブリュー,et al.  Active pharmaceutical ingredients self controlled release , 2013 .

[17]  Cui Tang,et al.  Size-dependent absorption mechanism of polymeric nanoparticles for oral delivery of protein drugs. , 2012, Biomaterials.

[18]  Justin L. Brown,et al.  Polymeric nanoparticles: the future of nanomedicine. , 2016, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[19]  Mitsuru Akashi,et al.  Polymerization within a molecular-scale stereoregular template , 2004, Nature.

[20]  M C Davies,et al.  Poly(organo phosphazene) nanoparticles surface modified with poly(ethylene oxide). , 1996, Biotechnology and bioengineering.

[21]  Yoshimune Nonomura,et al.  Non-Engineered Nanoparticles of C60 , 2013, Scientific Reports.

[22]  Guilin Wang,et al.  Recent developments in nanoparticle-based drug delivery and targeting systems with emphasis on protein-based nanoparticles. , 2008, Expert opinion on drug delivery.

[23]  Dong Soo Lee,et al.  Nanomedicine: Past, present and future - A global perspective. , 2015, Biochemical and biophysical research communications.

[24]  Pedro M. Valencia,et al.  Targeted Polymeric Therapeutic Nanoparticles: Design, Development and Clinical Translation , 2012 .

[25]  A. Osuna,et al.  Allopurinol encapsulated in polycyanoacrylate nanoparticles as potential lysosomatropic carrier: preparation and trypanocidal activity. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[26]  J. Kreuter,et al.  Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles) , 1995, Brain Research.

[27]  Yang Wang,et al.  Antibiotic-conjugated polyacrylate nanoparticles: new opportunities for development of anti-MRSA agents. , 2007, Bioorganic & medicinal chemistry letters.

[28]  Omid C. Farokhzad,et al.  Polymeric nanoparticle technologies for oral drug delivery. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[29]  J. Kreuter,et al.  Drug delivery to the central nervous system by polymeric nanoparticles: what do we know? , 2014, Advanced drug delivery reviews.

[30]  Cui Tang,et al.  Multifunctional polymeric nanoparticles for oral delivery of TNF-α siRNA to macrophages. , 2013, Biomaterials.

[31]  P. Iadarola,et al.  Enzyme loaded biodegradable microspheres in vitro ex vivo evaluation. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[32]  Kurt E. Geckeler,et al.  Polymer nanoparticles: Preparation techniques and size-control parameters , 2011 .

[33]  H. Federoff,et al.  Novel targets for CNS gene therapy , 1999, Gene Therapy.

[34]  Tze-Wen Chung,et al.  Effect of saturated/unsaturated phosphatidylcholine ratio on the stability of liposome-encapsulated hemoglobin , 1998 .

[35]  Andhra Pradesh,et al.  NANOPARTICLES AS DRUG DELIVERY SYSTEMS , 2012 .

[36]  Mansoor M Amiji,et al.  Gastrointestinal distribution and in vivo gene transfection studies with nanoparticles-in-microsphere oral system (NiMOS). , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[37]  Soundarapandian Kannan,et al.  Multifunctional HER2-antibody conjugated polymeric nanocarrier-based drug delivery system for multi-drug-resistant breast cancer therapy. , 2014, ACS applied materials & interfaces.

[38]  E. Panzarini,et al.  Nanomaterials and Autophagy: New Insights in Cancer Treatment , 2013, Cancers.

[39]  Gittith Sánchez,et al.  Cytotoxicity and trypanocidal activity of nifurtimox encapsulated in ethylcyanoacrylate nanoparticles. , 2002, Biological research.

[40]  O. Kayser,et al.  The impact of nanobiotechnology on the development of new drug delivery systems. , 2005, Current pharmaceutical biotechnology.

[41]  Zoran Markovic,et al.  Multiple mechanisms underlying the anticancer action of nanocrystalline fullerene. , 2007, European journal of pharmacology.

[42]  Hsing-Wen Sung,et al.  A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery. , 2011, Biomaterials.

[43]  T. Chang,et al.  Submicron polymer membrane hemoglobin nanocapsules as potential blood substitutes: preparation and characterization. , 1996, Artificial cells, blood substitutes, and immobilization biotechnology.

[44]  Jaleh Varshosaz,et al.  STABILITY IMPROVEMENT OF IMMOBILIZED ALKALINE PHOSPHATASE USING CHITOSAN NANOPARTICLES , 2016 .

[45]  Krishnendu Roy,et al.  Oral gene delivery with chitosan–DNA nanoparticles generates immunologic protection in a murine model of peanut allergy , 1999, Nature Medicine.

[46]  William A Weiss,et al.  Principles and Current Strategies for Targeting Autophagy for Cancer Treatment , 2011, Clinical Cancer Research.

[47]  Ruxandra Gref,et al.  Protein encapsulation within poly(ethylene glycol)-coated nanospheres. II. Controlled release properties. , 1999, Journal of biomedical materials research.

[48]  J. Kreuter,et al.  On the mechanism of termination in heterogeneous polymerization , 1982 .

[49]  W. Mark Saltzman,et al.  A holistic approach to targeting disease with polymeric nanoparticles , 2015, Nature Reviews Drug Discovery.

[50]  Li Ma,et al.  Influence of experimental parameters on chiral separation in SFC , 1994 .

[51]  Giuseppe Trapani,et al.  Characterization and evaluation of chitosan nanoparticles for dopamine brain delivery. , 2011, International journal of pharmaceutics.

[52]  Gerhard J. Mohr,et al.  Biocompatible fluorescent nanoparticles for pH-sensoring. , 2008, Soft matter.

[53]  Mansoor M Amiji,et al.  Polymeric nano- and microparticle technologies for oral gene delivery , 2007, Expert opinion on drug delivery.

[54]  Zeenat Iqbal,et al.  Biodegradable polymeric nanoparticles for oral delivery of epirubicin: In vitro, ex vivo, and in vivo investigations. , 2015, Colloids and surfaces. B, Biointerfaces.

[55]  W. Mark Saltzman,et al.  Nanosystems for simultaneous imaging and drug delivery to T cells , 2007, The AAPS Journal.

[56]  Ronnie Willaert,et al.  Assessment of stability, toxicity and immunogenicity of new polymeric nanoreactors for use in enzyme replacement therapy of MNGIE. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[57]  Kuiwon Choi,et al.  Photo-crosslinked hyaluronic acid nanoparticles with improved stability for in vivo tumor-targeted drug delivery. , 2013, Biomaterials.

[58]  Catarina Pinto Reis,et al.  Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles. , 2006, Nanomedicine : nanotechnology, biology, and medicine.

[59]  Barbara Luppi,et al.  Albumin nanoparticles carrying cyclodextrins for nasal delivery of the anti-Alzheimer drug tacrine. , 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[60]  Ronnie H. Fang,et al.  Large-scale synthesis of lipid-polymer hybrid nanoparticles using a multi-inlet vortex reactor. , 2012, Langmuir : the ACS journal of surfaces and colloids.

[61]  Sudesh Kumar Yadav,et al.  Biodegradable polymeric nanoparticles based drug delivery systems. , 2010, Colloids and surfaces. B, Biointerfaces.

[62]  Xinguo Jiang,et al.  Brain delivery property and accelerated blood clearance of cationic albumin conjugated pegylated nanoparticle. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[63]  C. Remuñán-López,et al.  Enhancement of Nasal Absorption of Insulin Using Chitosan Nanoparticles , 1999, Pharmaceutical Research.

[64]  Mansoor Amiji,et al.  Epidermal Growth Factor Receptor-Targeted Gelatin-Based Engineered Nanocarriers for DNA Delivery and Transfection in Human Pancreatic Cancer Cells , 2008, The AAPS Journal.

[65]  T. Chang,et al.  A new red blood cell substitute. , 2004, Critical care medicine.

[66]  Michele Zoli,et al.  Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transport. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[67]  Anthony E. Gregory,et al.  Vaccine delivery using nanoparticles , 2013, Front. Cell. Infect. Microbiol..

[68]  P. Legrand,et al.  Efficacy and Pharmacokinetics of Intravenous Nanocapsule Formulations of Halofantrine in Plasmodium berghei-Infected Mice , 2004, Antimicrobial Agents and Chemotherapy.

[69]  Christine Vauthier,et al.  Heparin coated poly(alkylcyanoacrylate) nanoparticles coupled to hemoglobin: a new oxygen carrier. , 2004, Biomaterials.

[70]  Robert Langer,et al.  Microfluidic platform for combinatorial synthesis and optimization of targeted nanoparticles for cancer therapy. , 2013, ACS nano.

[71]  Iqbal Ahmad,et al.  Induction of ROS, mitochondrial damage and autophagy in lung epithelial cancer cells by iron oxide nanoparticles. , 2012, Biomaterials.

[72]  Mohsin Shah,et al.  Amphiphilic PHA-mPEG copolymeric nanocontainers for drug delivery: preparation, characterization and in vitro evaluation. , 2010, International journal of pharmaceutics.

[73]  Mansoor Amiji,et al.  Biodistribution and Targeting Potential of Poly(ethylene glycol)-modified Gelatin Nanoparticles in Subcutaneous Murine Tumor Model , 2004, Journal of drug targeting.

[74]  Tarsem Sahota,et al.  In vivo study of a polymeric glucose-sensitive insulin delivery system using a rat model. , 2010, Journal of pharmaceutical sciences.

[75]  A. Bernkop‐Schnürch,et al.  Novel insulin thiomer nanoparticles: in vivo evaluation of an oral drug delivery system. , 2008, Biomacromolecules.

[76]  A. R. Kulkarni,et al.  Targeted nanoparticles for drug delivery through the blood-brain barrier for Alzheimer's disease. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[77]  Giuseppe Floris,et al.  Autophagy inhibition and antimalarials promote cell death in gastrointestinal stromal tumor (GIST) , 2010, Proceedings of the National Academy of Sciences.

[78]  A. Osuna,et al.  Pharmaceutics: Characterization and Trypanocidal Activity of Nifurtimox‐containing and Empty Nanoparticles of Polyethylcyanoacrylates , 1998, The Journal of pharmacy and pharmacology.

[79]  Ramon Eritja,et al.  Novel non-viral gene delivery systems composed of carbosilane dendron functionalized nanoparticles prepared from nano-emulsions as non-viral carriers for antisense oligonucleotides. , 2015, International journal of pharmaceutics.

[80]  Rishi Paliwal,et al.  Nanomedicine Scale-up Technologies: Feasibilities and Challenges , 2014, AAPS PharmSciTech.

[81]  V. Torchilin.  Recent advances with liposomes as pharmaceutical carriers , 2005, Nature Reviews Drug Discovery.

[82]  Sergey A. Piletsky,et al.  Influence of the Polymerization Conditions on the Performance of Molecularly Imprinted Polymers , 2009 .

[83]  Cui Tang,et al.  Effects of mannose density on in vitro and in vivo cellular uptake and RNAi efficiency of polymeric nanoparticles. , 2015, Biomaterials.

[84]  Barbara Ruozi,et al.  Development of Novel Zn2+ Loaded Nanoparticles Designed for Cell-Type Targeted Drug Release in CNS Neurons: In Vitro Evidences , 2011, PloS one.

[85]  R. Müller,et al.  Chemotherapy of brain tumour using doxorubicin bound to surfactant-coated poly(butyl cyanoacrylate) nanoparticles: revisiting the role of surfactants. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[86]  Khalid M El-Say,et al.  Development of alginate-reinforced chitosan nanoparticles utilizing W/O nanoemulsification/internal crosslinking technique for transdermal delivery of rabeprazole. , 2014, Life sciences.

[87]  Junji Watanabe,et al.  Sequential enzymatic reactions and stability of biomolecules immobilized onto phospholipid polymer nanoparticles. , 2006, Biomacromolecules.

[88]  Ali Khademhosseini,et al.  Biocompatibility of engineered nanoparticles for drug delivery. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[89]  H. Clark,et al.  Optical nanosensors for chemical analysis inside single living cells. 2. Sensors for pH and calcium and the intracellular application of PEBBLE sensors. , 1999, Analytical chemistry.

[90]  Zhen Gu,et al.  Emerging micro- and nanotechnology based synthetic approaches for insulin delivery. , 2014, Chemical Society reviews.

[91]  Wenhu Zhou,et al.  Aptamer-nanoparticle bioconjugates enhance intracellular delivery of vinorelbine to breast cancer cells , 2014, Journal of drug targeting.

[92]  Cui Tang,et al.  Oral delivery of shRNA and siRNA via multifunctional polymeric nanoparticles for synergistic cancer therapy. , 2014, Biomaterials.

[93]  Adil Denizli,et al.  New generation polymeric nanospheres for lysozyme adsorption , 2010 .

[94]  Kristofer J. Thurecht,et al.  Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date , 2016, Pharmaceutical Research.

[95]  Markus Antonietti,et al.  Polyreactions in miniemulsions , 2002 .

[96]  Federica Chiellini,et al.  Polymeric nanoparticles for hemoglobin-based oxygen carriers. , 2008, Biochimica et biophysica acta.

[97]  K. E. Geckeler,et al.  Polyreaktionen —Mechanismen, Systematik, Relevanz , 1993, Naturwissenschaften.

[98]  C Vigneron,et al.  Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion method. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[99]  S. Takeoka,et al.  Poly(ethylene glycol)-conjugation and deoxygenation enable long-term preservation of hemoglobin-vesicles as oxygen carriers in a liquid state. , 2000, Bioconjugate chemistry.

[100]  A. Lowman,et al.  Biodegradable nanoparticles for drug delivery and targeting , 2002 .

[101]  Toral Patel,et al.  Polymeric nanoparticles for drug delivery to the central nervous system. , 2012, Advanced drug delivery reviews.

[102]  A. Woolf,et al.  N-acetylcysteine reduces methemoglobin in vitro. , 1996, Annals of emergency medicine.

[103]  Shiladitya Sengupta,et al.  Clinical translational challenges in nanomedicine , 2014 .

[104]  Jian-Wen Wang,et al.  Preparation and adsorption properties of chitosan–poly(acrylic acid) nanoparticles for the removal of nickel ions , 2008 .

[105]  Sanghyo Kim,et al.  Polymer Nanoparticles for Smart Drug Delivery , 2014 .

[106]  Rajesh Pandey,et al.  Nano-encapsulation of azole antifungals: potential applications to improve oral drug delivery. , 2005, International journal of pharmaceutics.

[107]  M. Joshi,et al.  Parasitic diseases: Liposomes and polymeric nanoparticles versus lipid nanoparticles. , 2007, Advanced drug delivery reviews.

[108]  Yanli Zhao,et al.  Recent advances in biocompatible nanocarriers for delivery of chemotherapeutic cargoes towards cancer therapy. , 2014, Organic & biomolecular chemistry.

[109]  Karsten Haupt,et al.  Molecularly imprinted polymers as antibody and receptor mimics for assays, sensors and drug discovery , 2004, Analytical and bioanalytical chemistry.

[110]  Shan Jiang,et al.  Oral Administration and Selective Uptake of Polymeric Nanoparticles in Drosophila Larvae as an in Vivo Model. , 2015, ACS biomaterials science & engineering.

[111]  Patrick Hunziker,et al.  Challenges of clinical translation in nanomedicine: A qualitative study. , 2016, Nanomedicine : nanotechnology, biology, and medicine.

[112]  Robert J. Levy,et al.  Formulation and characterization of biodegradable nanoparticles for intravascular local drug delivery , 1997 .

[113]  W. Lin,et al.  Application of polymeric nanoparticles and micelles in insulin oral delivery , 2015, Journal of food and drug analysis.

[114]  K. Derakhshandeh,et al.  Encapsulation of 9-nitrocamptothecin, a novel anticancer drug, in biodegradable nanoparticles: factorial design, characterization and release kinetics. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[115]  Robert Langer,et al.  Biodegradable, polymeric nanoparticle delivery systems for cancer therapy. , 2007, Nanomedicine.

[116]  S. Bhaskaran,et al.  Recent trends in vaccine delivery systems: A review , 2011, International journal of pharmaceutical investigation.

[117]  Qing Liao,et al.  Ultrasensitive DNA detection using photonic crystals. , 2008, Angewandte Chemie.

[118]  Mansoor Amiji,et al.  Long-Circulating Poly(Ethylene Glycol)-Modified Gelatin Nanoparticles for Intracellular Delivery , 2002, Pharmaceutical Research.

[119]  T. Ficht,et al.  Polymeric particles in vaccine delivery. , 2010, Current opinion in microbiology.

[120]  Neil Desai,et al.  Challenges in Development of Nanoparticle-Based Therapeutics , 2012, The AAPS Journal.

[121]  Jinho Park,et al.  Targeting Strategies for Multifunctional Nanoparticles in Cancer Imaging and Therapy , 2012, Theranostics.

[122]  H. Yadav,et al.  DIFFERENT TECHNIQUES FOR PREPARATION OF POLYMERIC NANOPARTICLES-A , 2012 .

[123]  Wei Sun,et al.  Bioadhesion and oral absorption of enoxaparin nanocomplexes. , 2010, International journal of pharmaceutics.

[124]  Bernhard K. Keppler,et al.  Preclinical Development and First Clinical Studies of Budotitane , 1988 .

[125]  Yang Li,et al.  Autophagy-mediated chemosensitization in cancer cells by fullerene C60 nanocrystal , 2009, Autophagy.

[126]  Liang Zhao,et al.  Gefitinib loaded folate decorated bovine serum albumin conjugated carboxymethyl-beta-cyclodextrin nanoparticles enhance drug delivery and attenuate autophagy in folate receptor-positive cancer cells , 2014, Journal of Nanobiotechnology.

[127]  G. Sharma,et al.  Design of Biodegradable Nanoparticles for Oral Delivery of Doxorubicin: In vivo Pharmacokinetics and Toxicity Studies in Rats , 2009, Pharmaceutical Research.

[128]  Weihong Tan,et al.  Nanotechnology in therapeutics : a focus on nanoparticles as a drug delivery system Review , 2008 .

[129]  Guanghui Ma,et al.  Polymeric micro/nanoparticles: Particle design and potential vaccine delivery applications. , 2015, Vaccine.

[130]  Mohd Javed Akhtar,et al.  Targeted anticancer therapy: overexpressed receptors and nanotechnology. , 2014, Clinica chimica acta; international journal of clinical chemistry.

[131]  Kemin Wang,et al.  Nanoparticle-based biocompatible and long-life marker for lysosome labeling and tracking. , 2010, Analytical chemistry.

[132]  José M. Asua,et al.  Emulsion polymerization: From fundamental mechanisms to process developments , 2004 .

[133]  J. Kreuter,et al.  Nanoparticulate systems for brain delivery of drugs. , 2001, Advanced drug delivery reviews.

[134]  R. Tsien.  A non-disruptive technique for loading calcium buffers and indicators into cells , 1981, Nature.

[135]  M. R. Kumar,et al.  Impact of polymeric nanoparticles on oral pharmacokinetics: a dose-dependent case study with estradiol. , 2009, Journal of pharmaceutical sciences.

[136]  Christine Vauthier,et al.  Methods for the Preparation and Manufacture of Polymeric Nanoparticles , 2009, Pharmaceutical Research.

[137]  Ji Qian,et al.  Transfection of mEpo gene to intestinal epithelium in vivo mediated by oral delivery of chitosan-DNA nanoparticles. , 2004, World journal of gastroenterology.

[138]  Gary W. Poehlein,et al.  Kinetics of emulsifier‐free emulsion polymerization of styrene , 1990 .

[139]  Mansoor M. Amiji,et al.  Cellular uptake and concentrations of tamoxifen upon administration in poly(ε-caprolactone) nanoparticles , 2003, AAPS PharmSci.

[140]  Federica Chiellini,et al.  Hemoglobin loaded polymeric nanoparticles: preparation and characterizations. , 2011, European Journal of Pharmaceutical Sciences.

[141]  Thomas Hirt,et al.  Polymerized ABA Triblock Copolymer Vesicles , 2000 .

[142]  Raimar Löbenberg,et al.  Overview of the preparation of organic polymeric nanoparticles for drug delivery based on gelatine, chitosan, poly(d,l-lactide-co-glycolic acid) and polyalkylcyanoacrylate. , 2014, Colloids and surfaces. B, Biointerfaces.

[143]  Richard A Flavell,et al.  Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy. , 2009, Vaccine.

[144]  Laura M Ensign,et al.  Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers. , 2012, Advanced drug delivery reviews.

[145]  Ali Majdi,et al.  Nanotoxicology and nanoparticle safety in biomedical designs , 2011, International journal of nanomedicine.

[146]  W. Mark Saltzman,et al.  Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA , 2009, Nature materials.

[147]  F. Masood,et al.  Polymeric nanoparticles for targeted drug delivery system for cancer therapy. , 2016, Materials science & engineering. C, Materials for biological applications.

[148]  Peng Liu,et al.  Synthesis of monodispersed crosslinked nanoparticles decorated with surface carboxyl groups via soapless emulsion polymerization , 2010 .

[149]  B Ruozi,et al.  PLA/PLGA nanoparticles for sustained release of docetaxel. , 2006, International journal of pharmaceutics.

[150]  A. Bernkop‐Schnürch,et al.  Thiomers: development and in vitro evaluation of a peroral microparticulate peptide delivery system. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[151]  M C Davies,et al.  Detection and determination of surface levels of poloxamer and PVA surfactant on biodegradable nanospheres using SSIMS and XPS. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[152]  Patrick Couvreur,et al.  Controlled drug delivery with nanoparticles : current possibilities and future trends , 1995 .

[153]  Barbara Ruozi,et al.  The “fate” of polymeric and lipid nanoparticles for brain delivery and targeting: Strategies and mechanism of blood–brain barrier crossing and trafficking into the central nervous system , 2016 .

[154]  V. Préat,et al.  PLGA-based nanoparticles: an overview of biomedical applications. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[155]  Khalid M El-Say,et al.  Maximizing the Therapeutic Efficacy of Imatinib Mesylate-Loaded Niosomes on Human Colon Adenocarcinoma Using Box-Behnken Design. , 2017, Journal of pharmaceutical sciences.

[156]  J. Benoit,et al.  Design and production of nanoparticles formulated from nano-emulsion templates-a review. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[157]  Sergey A Piletsky,et al.  Advances in the manufacture of MIP nanoparticles. , 2010, Trends in biotechnology.

[158]  Xiaolan Zhang,et al.  Porosity and semipermeability of hemoglobin-loaded polymeric nanoparticles as potential blood substitutes. , 2009, Journal of biomedical materials research. Part B, Applied biomaterials.

[159]  Mansoor M. Amiji,et al.  Long-Circulating Polymeric Nanoparticles for Drug and Gene Delivery to Tumors , 2006 .

[160]  M A Vandelli,et al.  Potential use of polymeric nanoparticles for drug delivery across the blood-brain barrier. , 2013, Current medicinal chemistry.

[161]  K. S. Kumar,et al.  Chitosan nanoparticles as a new delivery system for the anti-Alzheimer drug tacrine. , 2010, Nanomedicine : nanotechnology, biology, and medicine.

[162]  G. P. Agrawal,et al.  Gelatin nanocarriers as potential vectors for effective management of tuberculosis. , 2010, International journal of pharmaceutics.

[163]  Frank F Bier,et al.  Construction of an artificial cell membrane anchor using DARC as a fitting for artificial extracellular functionalities of eukaryotic cells , 2012, Journal of Nanobiotechnology.

[164]  Xinguo Jiang,et al.  Influence of particle size on transport of methotrexate across blood brain barrier by polysorbate 80-coated polybutylcyanoacrylate nanoparticles. , 2006, International journal of pharmaceutics.

[165]  J. Vishwanatha,et al.  Scale up, optimization and stability analysis of Curcumin C3 complex-loaded nanoparticles for cancer therapy , 2012, Journal of Nanobiotechnology.

[166]  Mansoor M Amiji,et al.  Cellular uptake and concentrations of tamoxifen upon administration in poly(epsilon-caprolactone) nanoparticles. , 2003, AAPS pharmSci.

[167]  Antonello Barresi,et al.  Design and scale‐up of chemical reactors for nanoparticle precipitation , 2006 .

[168]  G. Challa,et al.  Polymerization of Methacrylic Acid in the Presence of Isotactic Poly(methyl Methacrylate) as Possible Template , 1980 .

[169]  Yan Liu,et al.  Self-Assembled Polymeric Micellar Nanoparticles as Nanocarriers for Poorly Soluble Anticancer Drug Ethaselen , 2009, Nanoscale research letters.

[170]  Stephan Marsch,et al.  Cell targeting by a generic receptor-targeted polymer nanocontainer platform. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[171]  D. A. Kharkevich,et al.  Delivery of Loperamide Across the Blood-Brain Barrier with Polysorbate 80-Coated Polybutylcyanoacrylate Nanoparticles , 1997, Pharmaceutical Research.

[172]  H. Maeda.  The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. , 2001, Advances in enzyme regulation.

[173]  C. Chern,et al.  Miniemulsion polymerization of styrene in the presence of a water-insoluble blue dye , 1998 .

[174]  Hannah Hoag.  Gene therapy rising? , 2005, Nature.

[175]  Liang Jiang,et al.  Antitumor effects of polysorbate-80 coated gemcitabine polybutylcyanoacrylate nanoparticles in vitro and its pharmacodynamics in vivo on C6 glioma cells of a brain tumor model , 2009, Brain Research.

[176]  Jing Xu,et al.  Non-condensing polymeric nanoparticles for targeted gene and siRNA delivery. , 2012, International journal of pharmaceutics.

[177]  Mansoor M. Amiji,et al.  Development of Novel Biodegradable Polymeric Nanoparticles-in-Microsphere Formulation for Local Plasmid DNA Delivery in the Gastrointestinal Tract , 2008, AAPS PharmSciTech.

[178]  Mohammad Reza Aghasadeghi,et al.  Polymeric nanoparticles , 2014, Human vaccines & immunotherapeutics.

[179]  Robert Langer,et al.  Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile , 2012, Science Translational Medicine.

[180]  Stephan Marsch,et al.  Inhibition of Macrophage Phagocytotic Activity by a Receptor-targeted Polymer Vesicle-based Drug Delivery Formulation of Pravastatin , 2008, Journal of cardiovascular pharmacology.

[181]  Stuart C. Thickett,et al.  Emulsion polymerization : State of the art in kinetics and mechanisms , 2007 .

[182]  M. Glatzel,et al.  Efficient systemic therapy of rat glioblastoma by nanoparticle-bound doxorubicin is due to antiangiogenic effects. , 2009, Clinical neuropathology.

[183]  Weihong Tan,et al.  Ultrasensitive DNA detection using highly fluorescent bioconjugated nanoparticles. , 2003, Journal of the American Chemical Society.

[184]  Shantikumar V. Nair,et al.  Preparation of poly(lactic acid)/chitosan nanoparticles for anti-HIV drug delivery applications , 2010 .

[185]  Ruth Duncan,et al.  Polymer therapeutics: Top 10 selling pharmaceuticals - what next? , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[186]  Christine Vauthier,et al.  Processing and Scale-up of Polymeric Nanoparticles , 2011 .

[187]  Mansoor Amiji,et al.  Oral TNF-α gene silencing using a polymeric microsphere-based delivery system for the treatment of inflammatory bowel disease. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[188]  Qiang Zhang,et al.  pH-sensitive polymeric nanoparticles to improve oral bioavailability of peptide/protein drugs and poorly water-soluble drugs. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[189]  Michele Zoli,et al.  Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[190]  J. Cassidy,et al.  Evaluating the potential of polymer nanoparticles for oral delivery of paclitaxel in drug-resistant cancer , 2010, Cancer nanotechnology.

[191]  B A Sabel,et al.  Influence of Nanoparticles on the Brain‐to‐serum Distribution and the Metabolism of Valproic Acid in Mice , 2000, The Journal of pharmacy and pharmacology.

[192]  Yang Yang,et al.  Oridonin, a diterpenoid purified from Rabdosia rubescens, inhibits the proliferation of cells from lymphoid malignancies in association with blockade of the NF-κB signal pathways , 2005, Molecular Cancer Therapeutics.

[193]  Samir Mitragotri,et al.  Challenges associated with Penetration of Nanoparticles across Cell and Tissue Barriers: A Review of Current Status and Future Prospects. , 2014, Nano today.

[194]  Y. Zhang,et al.  A functionalized single-walled carbon nanotube-induced autophagic cell death in human lung cells through Akt–TSC2-mTOR signaling , 2011, Cell Death and Disease.

[195]  R Langer,et al.  Bioerodible polyanhydrides as drug-carrier matrices. I: Characterization, degradation, and release characteristics. , 1985, Journal of biomedical materials research.

[196]  Fan Wu,et al.  Preparation of hemoglobin-loaded nano-sized particles with porous structure as oxygen carriers. , 2007, Biomaterials.

[197]  Ann-Christine Albertsson,et al.  Degradable polymer microspheres for controlled drug delivery , 2002 .

[198]  Brigitta Loretz,et al.  Oral gene delivery: Strategies to improve stability of pDNA towards intestinal digestion , 2006, Journal of drug targeting.

[199]  Arthur G Erdman,et al.  The big picture on nanomedicine: the state of investigational and approved nanomedicine products. , 2013, Nanomedicine : nanotechnology, biology, and medicine.

[200]  Ging-Ho Hsiue,et al.  Preparation and characterization of intelligent core-shell nanoparticles based on poly(D,L-lactide)-g-poly(N-isopropyl acrylamide-co-methacrylic acid). , 2005, Journal of controlled release : official journal of the Controlled Release Society.